Information Library
In the News Articles - Market Access
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Patient Outcomes and Health Economics
September 25, 2009
Across Europe the impetus to measure patient outcomes and demonstrate positive health economic benefits is intensifying. Jacco Keja, Managing Director and Practice Leader at Quintiles Consulting, visiting Professor Life Sciences Pricing, Erasmus University, looks at the emerging opportunities for pharma companies within this environment. -
A New Gold Standard for Pricing
September 26, 2008
Dr. John Doyle, practice leader for market access at Quintiles Consulting, introduces the concept of a health economic balance sheet and evidence-based pricing for biopharmaceutical valuation.
Page 1 of 1 (2 items)